Relative Risk and Incidence for Developmental Dysplasia of the Hip

Virginie Pollet1, Vanessa Percy2, Heather J Prior3

  • 1Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.

The Journal of Pediatrics
|November 22, 2016
PubMed

Insights

Developmental dysplasia of the hip (DDH) affects 6.6/1000 newborns. Female, first-born infants with clubfoot or breech presentation have higher risks, with rural births presenting later.

Area of Science:

  • Orthopedics
  • Pediatrics
  • Public Health

Background:

  • Developmental dysplasia of the hip (DDH) is a condition affecting hip joint development in infants.
  • Early detection and intervention are crucial for optimal outcomes in DDH management.
  • Understanding incidence and risk factors in populations without universal screening is essential for public health strategies.

Purpose of the Study:

  • To determine the incidence of DDH in a contemporary population.
  • To identify associated risk factors for DDH in newborns.
  • To analyze regional variations in DDH presentation and diagnosis.

Main Methods:

  • Retrospective cohort study using health administrative data (1995-2012) and imaging reviews (2004-2012).
  • Inclusion of all live births in Manitoba, Canada.
  • Statistical analysis using chi-squared tests to assess relative risks of identified factors.

Main Results:

  • Overall DDH incidence was 6.6 per 1000 newborns; late-presenting DDH occurred in 2.2 per 1000.
  • Significant risk factors included female sex, first-born status, breech presentation, and clubfoot deformity.
  • Children in rural Northern/Central Manitoba had later DDH presentation compared to urban counterparts (P < .0001).

Conclusions:

  • The study highlights the continued incidence of DDH and identifies key risk factors.
  • Regional disparities in presentation age suggest potential barriers to early detection in rural areas.
  • Enhanced awareness of risk factors and regional differences is needed at well-baby clinics for improved early DDH detection.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.2K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.4K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Probability Laws01:49

Probability Laws

Overview
44.7K